This is the second article dedicated to The Annual 40th Congress of the International Society of Oncology and Biomarkers, which took place in Jerusalem, Israel. This second part of this article will be dedicated to the special presentations from individual sessions. Sessions were organised according to the cancer type or etiopathogenesis, while some sessions were dedicated to the relationship between diagnostics and therapy choice.